- Home
- LSTA vs IINN Comparison
LSTA vs IINN Comparison
Compare LSTA & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- IINN
- Stock Information
- Founded
- LSTA 1980
- IINN 2018
- Country
- LSTA United States
- IINN Israel
- Employees
- LSTA N/A
- IINN N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- IINN Medical/Dental Instruments
- Sector
- LSTA Health Care
- IINN Health Care
- Exchange
- LSTA Nasdaq
- IINN Nasdaq
- Market Cap
- LSTA 31.2M
- IINN 25.9M
- IPO Year
- LSTA N/A
- IINN 2021
- Fundamental
- Price
- LSTA $3.71
- IINN $1.06
- Analyst Decision
- LSTA Strong Buy
- IINN
- Analyst Count
- LSTA 1
- IINN 0
- Target Price
- LSTA $15.00
- IINN N/A
- AVG Volume (30 Days)
- LSTA 53.5K
- IINN 1.8M
- Earning Date
- LSTA 02-27-2025
- IINN 08-15-2024
- Dividend Yield
- LSTA N/A
- IINN N/A
- EPS Growth
- LSTA N/A
- IINN N/A
- EPS
- LSTA N/A
- IINN N/A
- Revenue
- LSTA N/A
- IINN N/A
- Revenue This Year
- LSTA N/A
- IINN N/A
- Revenue Next Year
- LSTA N/A
- IINN N/A
- P/E Ratio
- LSTA N/A
- IINN N/A
- Revenue Growth
- LSTA N/A
- IINN N/A
- 52 Week Low
- LSTA $2.19
- IINN $0.80
- 52 Week High
- LSTA $4.20
- IINN $2.45
- Technical
- Relative Strength Index (RSI)
- LSTA 66.07
- IINN 46.38
- Support Level
- LSTA $3.52
- IINN $1.00
- Resistance Level
- LSTA $3.87
- IINN $1.11
- Average True Range (ATR)
- LSTA 0.29
- IINN 0.11
- MACD
- LSTA 0.02
- IINN 0.01
- Stochastic Oscillator
- LSTA 63.97
- IINN 67.27
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.